LITFULO

DRUG3 trials

Sponsors

Pfizer, Centre Hospitalier Universitaire de Nice

Conditions

Alopecia AreataSevere Alopecia AreataVitiligo

Phase 2

Combination Approach With Ritlecitinib and nbUVB Compared to Ritlecitinib Alone for Treating Vitiligo

RecruitingNCT07152626

Centre Hospitalier Universitaire de NiceVitiligo

Start: 2026-03-12End: 2029-06-01Target: 56Updated: 2026-05-20

Unknown Phase

Litfulo Capsules Special Investigation

Active, not recruitingNCT06279221

PfizerAlopecia Areata

Start: 2024-03-01End: 2030-01-18Updated: 2026-08-27

A Study to Learn About Litfulo Capsule in People With Severe Alopecia Areata in Routine Clinical Practice.

RecruitingNCT07152119

PfizerSevere Alopecia Areata

Start: 2025-08-27End: 2030-03-23Target: 3000Updated: 2026-05-18